{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:56:03Z","timestamp":1760709363861},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Shiraz clinical microbiology research center","award":["91-16","91-17"],"award-info":[{"award-number":["91-16","91-17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12985-017-0797-2","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T12:19:14Z","timestamp":1499775554000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV\/HCV co-infected illicit drug users"],"prefix":"10.1186","volume":"14","author":[{"given":"Marzieh","family":"Jamalidoust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandana","family":"Namayandeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Moghadami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazyar","family":"Ziyaeyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,11]]},"reference":[{"key":"797_CR1","volume-title":"Diagnosis of viral hepatitis","author":"PJ Easterbrook","year":"2017","unstructured":"Easterbrook, P.J., et al., Diagnosis of viral hepatitis. Curr Opin HIV AIDS, 2017."},{"issue":"1 Suppl","key":"797_CR2","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","volume":"44","author":"MJ Alter","year":"2006","unstructured":"Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44(1 Suppl):S6\u20139.","journal-title":"J Hepatol"},{"key":"797_CR3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1471-2334-14-222","volume":"14","author":"AR Garbuglia","year":"2014","unstructured":"Garbuglia AR, et al. HCV core antigen and HCV-RNA in HIV\/HCV co-infected patients with different HCV genotypes. BMC Infect Dis. 2014;14:222.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"797_CR4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/339042","volume":"34","author":"KE Sherman","year":"2002","unstructured":"Sherman KE, et al. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34(6):831\u20137.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"797_CR5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.drugpo.2015.07.004","volume":"26","author":"DJ Smith","year":"2015","unstructured":"Smith DJ, et al. Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): a systematic review and meta-analysis. Int J Drug Policy. 2015;26(10):911\u201321.","journal-title":"Int J Drug Policy"},{"key":"797_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijid.2015.09.022","volume":"40","author":"M Malekinejad","year":"2015","unstructured":"Malekinejad M, et al. High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012). Int J Infect Dis. 2015;40:116\u201330.","journal-title":"Int J Infect Dis"},{"issue":"3","key":"797_CR7","first-page":"221","volume":"50","author":"M Lichterfeld","year":"2005","unstructured":"Lichterfeld M, et al. Clinical outcomes of HIV-HCV co-infection in a large cohort of hemophiliac patients. J Inf Secur. 2005;50(3):221\u20138.","journal-title":"J Inf Secur"},{"issue":"9","key":"797_CR8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/QAD.0b013e3283391d11","volume":"24","author":"EE Page","year":"2010","unstructured":"Page EE, et al. Clearance of hepatitis C virus RNA from serum in HIV\/hepatitis C virus coinfection indicates eradication from peripheral blood mononuclear cells. AIDS. 2010;24(9):1267\u201371.","journal-title":"AIDS"},{"key":"797_CR9","doi-asserted-by":"crossref","unstructured":"The Nerve Growth Factor: thirty-five years later. EMBO J, 1987. 6(9): p. 2856.","DOI":"10.1002\/j.1460-2075.1987.tb02583.x"},{"issue":"6","key":"797_CR10","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/jhep.2001.29201","volume":"34","author":"V Martino Di","year":"2001","unstructured":"Di Martino V, et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology. 2001;34(6):1193\u20139.","journal-title":"Hepatology"},{"issue":"6","key":"797_CR11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2893.2006.00816.x","volume":"14","author":"MS Sulkowski","year":"2007","unstructured":"Sulkowski MS, Benhamou Y. Therapeutic issues in HIV\/HCV-coinfected patients. J Viral Hepat. 2007;14(6):371\u201386.","journal-title":"J Viral Hepat"},{"issue":"2","key":"797_CR12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/blood.V81.2.412.412","volume":"81","author":"CL Troisi","year":"1993","unstructured":"Troisi CL, et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood. 1993;81(2):412\u20138.","journal-title":"Blood"},{"issue":"Suppl 1","key":"797_CR13","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/QAI.0000000000000124","volume":"66","author":"DO Kimanga","year":"2014","unstructured":"Kimanga DO, et al. Prevalence and incidence of HIV infection, trends, and risk factors among persons aged 15-64 years in Kenya: results from a nationally representative study. J Acquir Immune Defic Syndr. 2014;66(Suppl 1):S13\u201326.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9244","key":"797_CR14","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","volume":"356","author":"G Greub","year":"2000","unstructured":"Greub G, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV cohort study. Lancet. 2000;356(9244):1800\u20135.","journal-title":"Lancet"},{"key":"797_CR15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-6405-11-16","volume":"11","author":"C Beisel","year":"2014","unstructured":"Beisel C, et al. German cohort of HCV mono-infected and HCV\/HIV co-infected patients reveals relative under-treatment of co-infected patients. AIDS Res Ther. 2014;11:16.","journal-title":"AIDS Res Ther"},{"issue":"12","key":"797_CR16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082230","volume":"8","author":"B Honarvar","year":"2013","unstructured":"Honarvar B, et al. Blood-borne hepatitis in opiate users in iran: a poor outlook and urgent need to change nationwide screening policy. PLoS One. 2013;8(12):e82230.","journal-title":"PLoS One"},{"issue":"1","key":"797_CR17","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.7991","volume":"13","author":"F Jahanbakhsh Sefidi","year":"2013","unstructured":"Jahanbakhsh Sefidi F, et al. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013;13(1):e7991.","journal-title":"Hepat Mon"},{"issue":"1","key":"797_CR18","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.ijid.2009.03.002","volume":"14","author":"A Rahimi-Movaghar","year":"2010","unstructured":"Rahimi-Movaghar A, et al. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran. Iran Int J Infect Dis. 2010;14(1):e28\u201333.","journal-title":"Iran Int J Infect Dis"},{"issue":"9","key":"797_CR19","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jmv.23626","volume":"85","author":"H Abe","year":"2013","unstructured":"Abe H, et al. New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection. J Med Virol. 2013;85(9):1523\u201333.","journal-title":"J Med Virol"},{"issue":"4","key":"797_CR20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00042560-200104010-00008","volume":"26","author":"M Bonacini","year":"2001","unstructured":"Bonacini M, Lin HJ, Hollinger FB. Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus. J Acquir Immune Defic Syndr. 2001;26(4):340\u20134.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"797_CR21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1128\/CDLI.8.4.690-694.2001","volume":"8","author":"JM Matthews-Greer","year":"2001","unstructured":"Matthews-Greer JM, et al. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin Diagn Lab Immunol. 2001;8(4):690\u20134.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11","key":"797_CR22","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1086\/587843","volume":"197","author":"M Danta","year":"2008","unstructured":"Danta M, et al. Impact of HIV on host-virus interactions during early hepatitis C virus infection. J Infect Dis. 2008;197(11):1558\u201366.","journal-title":"J Infect Dis"},{"issue":"4","key":"797_CR23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/519386","volume":"196","author":"C Morishima","year":"2007","unstructured":"Morishima C, et al. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV\/HIV coinfection. J Infect Dis. 2007;196(4):577\u201386.","journal-title":"J Infect Dis"},{"issue":"15","key":"797_CR24","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1128\/JVI.00191-09","volume":"83","author":"Y Rotman","year":"2009","unstructured":"Rotman Y, Liang TJ. Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes. J Virol. 2009;83(15):7366\u201374.","journal-title":"J Virol"},{"issue":"19","key":"797_CR25","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.3748\/wjg.v20.i19.5897","volume":"20","author":"M Jamalidoust","year":"2014","unstructured":"Jamalidoust M, et al. Determining hepatitis C virus genotype distribution among high-risk groups in Iran using real-time PCR. World J Gastroenterol. 2014;20(19):5897\u2013902.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"797_CR26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1096-9071(199604)48:4<339::AID-JMV7>3.0.CO;2-8","volume":"48","author":"A Berger","year":"1996","unstructured":"Berger A, et al. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. J Med Virol. 1996;48(4):339\u201343.","journal-title":"J Med Virol"},{"issue":"4","key":"797_CR27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00002030-199804000-00006","volume":"12","author":"L Piroth","year":"1998","unstructured":"Piroth L, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS. 1998;12(4):381\u20138.","journal-title":"AIDS"},{"issue":"7","key":"797_CR28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101760","volume":"9","author":"S Corchado","year":"2014","unstructured":"Corchado S, et al. Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV\/HCV coinfected patients. PLoS One. 2014;9(7):e101760.","journal-title":"PLoS One"},{"issue":"5","key":"797_CR29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","volume":"351","author":"FJ Torriani","year":"2004","unstructured":"Torriani FJ, et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med. 2004;351(5):438\u201350.","journal-title":"N Engl J Med"},{"issue":"6","key":"797_CR30","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1086\/377585","volume":"188","author":"M Hisada","year":"2003","unstructured":"Hisada M, et al. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II. J Infect Dis. 2003;188(6):891\u20137.","journal-title":"J Infect Dis"},{"issue":"4","key":"797_CR31","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jhep.2011.11.008","volume":"56","author":"K Neukam","year":"2012","unstructured":"Neukam K, et al. Prediction of response to pegylated interferon plus ribavirin in HIV\/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load. J Hepatol. 2012;56(4):788\u201394.","journal-title":"J Hepatol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-017-0797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T19:21:58Z","timestamp":1659208918000},"score":1,"resource":{"primary":{"URL":"http:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-017-0797-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,11]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["797"],"URL":"https:\/\/doi.org\/10.1186\/s12985-017-0797-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,11]]},"article-number":"127"}}